vs
Side-by-side financial comparison of DESWELL INDUSTRIES INC (DSWL) and MYERS INDUSTRIES INC (MYE). Click either name above to swap in a different company.
Deswell Industries Inc is a global manufacturing firm producing plastic injection molded components, consumer audio products and small electronics. It delivers custom manufacturing solutions for OEM clients across North America, Europe and Asia, serving consumer goods and industrial operation segments.
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid ...
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $204.0M | ||
| Q3 25 | — | $205.4M | ||
| Q2 25 | — | $209.6M | ||
| Q1 25 | — | $206.8M | ||
| Q4 24 | — | $203.9M | ||
| Q3 24 | — | $205.1M | ||
| Q2 24 | — | $220.2M | ||
| Q1 24 | — | $207.1M |
| Q4 25 | — | $11.3M | ||
| Q3 25 | — | $7.1M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $6.8M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $-10.9M | ||
| Q2 24 | — | $10.3M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | — | 33.7% | ||
| Q1 25 | — | 33.4% | ||
| Q4 24 | — | 32.3% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 34.3% | ||
| Q1 24 | — | 31.0% |
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 8.6% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | — | -2.3% | ||
| Q2 24 | — | 10.8% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 3.5% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | -5.3% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | — | $0.30 | ||
| Q3 25 | — | $0.19 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.18 | ||
| Q4 24 | — | $0.11 | ||
| Q3 24 | — | $-0.29 | ||
| Q2 24 | — | $0.28 | ||
| Q1 24 | — | $0.09 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
